Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Immucor seeks FDA nod for blood bank technology:

This article was originally published in Clinica

Executive Summary

Immucor, a provider of automated instrument-reagent systems to the blood transfusion industry, has submitted a 510(k) marketing application to the US FDA for its Galileo instrument. The product is a high-throughput, highly automated blood bank system. It was launched in Europe in mid 2002. Edward Gallup, the Norcross, Georgia firm's chairman and CEO, said that "at the end of November 2003, the company had 93 placements."

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT057216

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel